CINECA IRIS Institutional Research Information System

DE BORTOLI, NICOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.984
EU - Europa 3.426
AS - Asia 1.694
AF - Africa 148
SA - Sud America 46
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 6
Totale 14.324
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.798
IT - Italia 1.518
CN - Cina 684
SE - Svezia 536
SG - Singapore 517
BG - Bulgaria 387
GB - Regno Unito 229
DE - Germania 222
VN - Vietnam 198
CA - Canada 179
TR - Turchia 132
FI - Finlandia 106
AT - Austria 94
CI - Costa d'Avorio 90
UA - Ucraina 82
HK - Hong Kong 49
IN - India 49
CH - Svizzera 45
FR - Francia 35
PL - Polonia 31
NL - Olanda 29
RU - Federazione Russa 26
NG - Nigeria 23
SN - Senegal 23
BE - Belgio 20
AU - Australia 17
ES - Italia 17
BR - Brasile 16
PT - Portogallo 14
KR - Corea 12
NO - Norvegia 12
IR - Iran 10
JP - Giappone 10
CL - Cile 8
EG - Egitto 8
AR - Argentina 7
CO - Colombia 7
MX - Messico 7
EU - Europa 6
EC - Ecuador 5
SK - Slovacchia (Repubblica Slovacca) 5
AE - Emirati Arabi Uniti 4
CZ - Repubblica Ceca 4
ID - Indonesia 4
IL - Israele 4
RS - Serbia 4
GR - Grecia 3
MY - Malesia 3
NZ - Nuova Zelanda 3
PE - Perù 3
PH - Filippine 3
PK - Pakistan 3
TH - Thailandia 3
TW - Taiwan 3
AZ - Azerbaigian 2
BJ - Benin 2
DK - Danimarca 2
AL - Albania 1
BD - Bangladesh 1
BN - Brunei Darussalam 1
DZ - Algeria 1
ET - Etiopia 1
IE - Irlanda 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LT - Lituania 1
LU - Lussemburgo 1
RO - Romania 1
Totale 14.324
Salva come PNG Salva come JPEG
Città #
Fairfield 1.097
Woodbridge 1.034
Houston 785
Ann Arbor 759
Chandler 616
Ashburn 553
Seattle 490
Serra 454
Cambridge 396
Sofia 387
Wilmington 383
Milan 361
Singapore 276
New York 261
Boardman 223
Beijing 203
Princeton 184
Santa Clara 181
Ottawa 164
Lawrence 153
Medford 145
London 110
Jacksonville 109
Nanjing 98
Dong Ket 94
Abidjan 90
Des Moines 86
Dearborn 85
Vienna 83
Florence 71
Istanbul 66
Izmir 60
Pisa 55
San Diego 49
Redwood City 47
Rome 45
Bern 43
Hong Kong 42
Nanchang 41
Lucca 31
Ogden 30
Falls Church 29
Washington 27
Hyderabad 26
Shenyang 25
Changsha 24
Dakar 23
Fuzhou 23
Kunming 23
Lagos 23
Los Angeles 23
Bremen 22
Phoenix 22
Shanghai 22
Lancaster 21
Brussels 19
Hebei 19
Jüchen 18
Dallas 15
Guangzhou 14
Norwalk 13
Alessandria 12
Boulder 12
Hefei 12
Chicago 11
Helsinki 11
Redmond 11
Southend 11
Council Bluffs 10
Lisbon 10
Nowy Sacz 10
Quanzhou 10
Amsterdam 9
Auburn Hills 9
Empoli 9
Groningen 9
Kent 9
Bergen 8
Livorno 8
Shenzhen 8
Toronto 8
Castelnovo di Sotto 7
Frankfurt am Main 7
Hangzhou 7
Tianjin 7
Warsaw 7
Cairo 6
Melbourne 6
Pescia 6
Pune 6
São Paulo 6
Xiamen 6
Atlanta 5
Buenos Aires 5
Genoa 5
Indiana 5
Jiaxing 5
Jinan 5
Munich 5
Pietrasanta 5
Totale 11.179
Salva come PNG Salva come JPEG
Nome #
Evaluation of Pancreatic Exocrine Function in Patients With Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas 321
Management of Chronic constipation in general practice 184
Symptom analysis improves GERD diagnosis and may be helpful to define a successful surgical approach 167
Randomised clinical trial: twice daily esomeprazole 40 mg vs. pantoprazole 40 mg in Barrett’s oesophagus for 1 year 162
Neuroendocrine Dysregulation in Irritable Bowel Syndrome Patients: A Pilot Study 161
Helicobacter pylori eradication: a randomized prospective study of triple therapy versus triple therapy plus lactoferrin and probiotics 159
Lactobacillus Casei DG® in Patients with Irritable Bowel Syndrome: Not Only a Change of the Gut Microbiota. A Pilot Study 158
Esophageal chemical clearance and baseline impedance values in patients with chronic autoimmune atrophic gastritis and gastro-esophageal reflux disease 155
Gastroesophageal reflux symptoms among Italian university students: Epidemiology and dietary correlates using automatically recorded transactions 148
Not all anti-reflux treatment failures are due to persistence of abnormal esophageal acid exposure 142
Influence of the serotonin transporter 5HTTLPR polymorphism on symptom severity in irritable bowel syndrome 142
Intestinal pseudo-obstruction in inactive systemic lupus erythematosus: An unusual finding 138
Management of chronic constipation in general practice. 137
Overlap of functional heartburn and gastroesophageal reflux disease with irritable bowel syndrome 137
Radionuclide evaluation of the lower gastrointestinal tract 137
Thrombocytopenic purpura: an unusual complication of eradication therapy for Helicobacter pylori 136
Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they? 130
Ambulatory reflux monitoring for diagnosis of gastro-esophageal reflux disease: Update of the Porto consensus and recommendations from an international consensus group 128
Suspected laryngopharyngeal reflux evaluated with multichannel impedance and Ph-monitoring. How many are gerd patients? 125
Could double-dose PPI therapy modify tissutal homeostasis in patients with barrett esophagus? 123
Genetics and pharmacogenetics of aminergic transmitter pathways in functional gastrointestinal disorders 123
Subthreshold psychiatric psychopathology in Functional gastrointestinal disorders: Can it be the bridge between gastroenterology and psychiatry? 122
Assessment of serum cytokines predicts clinical and endoscopic outcomes to vedolizumab in ulcerative colitis patients 121
Voluntary and controlled weight loss can reduce symptoms and proton pump inhibitor use and dosage in patients with gastroesophageal reflux disease: A comparative study 120
Accuracy of b-GGT fraction for the diagnosis of non-alcoholic fatty liver disease 119
The pharmacokinetics of ilaprazole for gastro-esophageal reflux treatment 119
Association between baseline impedance values and response proton pump inhibitors in patients with heartburn 118
How many cases of laryngopharyngeal reflux suspected by laryngoscopy are gastroesophageal reflux disease-related? 117
Gastroesophageal reflux disease, functional dyspepsia and irritable bowel syndrome: Common overlapping gastrointestinal disorders 116
Assessment of the anti-reflux properties and therapeutic efficacy of Faringel in patients with mild to moderate GERD. 114
“PancPro” as a tool for selecting families eligible for pancreatic cancer screening: An Italian study of incident cases 113
Manually calculated oesophageal bolus clearance time increases in parallel with reflux severity at impedance-pH monitoring 113
Barrett's esophagus in 2016: From pathophysiology to treatment 112
Patients with lactose intolerance absorb liquid levothyroxine better than tablet levothyroxine 111
Pre-operative clinical and instrumental factors as antireflux surgery outcome predictors 111
Pros and Cons of the SeHCAT Test in Bile Acid Diarrhea: A More Appropriate Use of an Old Nuclear Medicine Technique 111
Irritable bowel syndrome and chronic constipation: Fact and fiction 110
Esophageal testing: What we have so far 109
Lower pH values of weakly acidic refluxes as determinants of heartburn perception in gastroesophageal reflux disease patients with normal esophageal acid exposure 109
Antimicrobial treatment with the fixed-dose antibiotic combination RHB-104 for Mycobacterium avium subspecies paratuberculosis in Crohn’s disease: pharmacological and clinical implications 107
Assessment of bowel wall inflammation in Crohn's disease by a new quantitative ultrasound analysis as compared to vascularization in healthy volunteers bowel wall. 106
Clinical and pathophysiological outcomes of the robotic-assisted Heller–Dor myotomy for achalasia: a single-center experience 106
Nuclear translocation of GSTO is a progression marker in Barrett’s esophagus. 105
The natural history of gastro-esophageal reflux disease: A comprehensive review 105
Advancements in the use of manometry and impedance testing for esophageal functional disorders 105
Serum pepsinogen I and gastrin-17 levels are predictable of atrophic gastritis in patients with autoimmune thyroiditis and anti-gastric parietal cell autoantibodies. 104
Esophageal motility abnormalities in gastroesophageal reflux disease 104
Esophageal baseline impedance levels in patients with pathophysiological characteristics of functional heartburn. 104
Impairment of chemical clearance and mucosal integrity distinguishes hypersensitive esophagus from functional heartburn 103
Bioelectrical impedance vector analysis in patients with irritable bowel syndrome on a low FODMAP diet: a pilot study 101
Alginate controls heartburn in patients with erosive and nonerosive reflux disease 100
The added diagnostic value of postreflux swallow-induced peristaltic wave index and nocturnal baseline impedance in refractory reflux disease studied with on-therapy impedance-pH monitoring 100
Vonoprazan fumarate for the management of acid-related diseases 99
Evaluation of latent links between irritable bowel syndrome and sleep quality 99
Serum oncostatin M at baseline predicts mucosal healing in Crohn's disease patients treated with infliximab 99
Efficacy of Nissen fundoplication versus medical therapy in the regression of low-grade dysplasia in patients with Barrett esophagus: a prospective study 98
Eosinophilic esophagitis: Update in diagnosis and management. Position paper by the Italian Society of Gastroenterology and Gastrointestinal Endoscopy (SIGE) 98
GSTO: new marker of progression from barrett’s esophagus to adenocarcinoma. 97
Gastrointestinal involvement in systemic sclerosis 97
Achalasia with dense eosinophilic infiltrate responds to steroid therapy 97
Eating habits trajectories of students using university canteens 97
Optimal treatment of laryngopharyngeal reflux disease 97
Nuclear translocation of glutathione transferase omega is a progression marker in Barrett's esophagus 96
N-terminal pro-brain natriuretic peptide and tumor necrosis factor-alpha both are increased in patients with Hepatitis C. 96
Lactoferrin and probiotic can improve Helicobacter pylori eradication rate of triple standard therapy. 95
Are PPI responder patients always confirmed as GERD patients? A MII-PH study. 95
Presbifagia Esofagea 94
Vigor of peristalsis during multiple rapid swallows is inversely correlated with acid exposure time in patients with NERD 92
Vonoprazan for treatment of gastroesophageal reflux: pharmacodynamic and pharmacokinetic considerations 91
Unspecified intestinal malabsorption in patients treated with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers: a retrospective analysis in primary care settings 90
Analyses of the Post-reflux Swallow-induced Peristaltic Wave Index and Nocturnal Baseline Impedance Parameters Increase the Diagnostic Yield of Impedance-pH Monitoring of Patients With Reflux Disease 88
Are IBS patients alexithymic? 87
Updates in the field of non-esophageal gastroesophageal reflux disorder 87
Optimal management of constipation associated with irritable bowel syndrome 86
Interstitial lung disease in systemic sclerosis patients may benefit more from anti-reflux therapies than from immunosuppressants 86
Brachytherapy for the palliation of dysphagia owing to esophageal cancer: A systematic review and meta-analysis of prospective studies 86
Vegetal and Animal Food Proteins Have a Different Impact in the First Postprandial Hour of Impedance-pH Analysis in Patients with Heartburn 86
Corticosteroid Treatment at Diagnosis: An Analysis of Relapses, Disease Extension, and Colectomy Rate in Ulcerative Colitis 86
Relationship of TT virus and Helicobacter pilori infections in gastric tissues of patients with gastritis 85
A review of pharmacotherapy for treating gastroesophageal reflux disease (GERD) 85
Patients Who Respond to PPI Therapy are Always Considered GERD Patients? a MII-pH Study. 84
PP-6 BOLUS CLEARANCE TIME IS ASSOCIATED WITH REFLUX SEVERITY AND IT IS INVERSELY CORRELATED TO BASELINE IMPEDANCE VALUES IN ADOLESCENTS WITH GASTROESOPHAGEAL REFLUX DISEASE 84
Functional Heartburn Overlaps With Irritable Bowel Syndrome More Often than GERD 84
Antimicrobial treatment with the fixed-dose antibiotic combination RHB-104 for Mycobacterium avium subspecies paratuberculosis in Crohn’s disease: pharmacological and clinical implications 84
High Resolution and High Definition Anorectal Manometry 83
Esophagogastric junction morphology is associated with a positive impedance-pH monitoring in patients with GERD 82
Critical appraisal of Rome IV criteria: hypersensitive esophagus does belong to gastroesophageal reflux disease spectrum 82
Current and future perspectives in the management of gastroesophageal reflux disease 82
Microscopic esophagitis distinguishes patients with non-erosive reflux disease from those with functional heartburn 81
Jackhammer esophagus with and without esophagogastric junction outflow obstruction demonstrates altered neural control resembling type 3 achalasia 81
Perceptual and multiparametric analysis of the voice in GERD patients 80
Practice guidelines on the use of esophageal manometry - A GISMAD-SIGE-AIGO medical position statement 80
Underuse of brachytherapy for the treatment of dysphagia owing to esophageal cancer. An Italian survey 80
The placebo effect is a relevant factor in evaluating effectiveness of therapies in functional gastrointestinal disorders 79
The appropriate use of proton pump inhibitors (PPIs): Need for a reappraisal 79
Postreflux swallow-induced peristaltic wave index and nocturnal baseline impedance can link PPI-responsive heartburn to reflux better than acid exposure time 79
Low FODMAP diet: Evidence, doubts, and hopes 79
Reflux pattern and role of impedance-pH variables in predicting PPI response in patients with suspected GERD-related chronic cough 77
High-resolution manometry is superior to endoscopy and radiology in assessing and grading sliding hiatal hernia: A comparison with surgical in vivo evaluation 77
Bile reflux in patients with nerd is associated with more severe heartburn and lower values of mean nocturnal baseline impedance and chemical clearance 77
Totale 10.831
Salva come PNG Salva come JPEG
Categoria #
all - tutte 48.171
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.171
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.908 0 0 0 0 267 327 299 247 310 166 216 76
2020/20211.385 104 83 89 145 109 59 91 109 142 107 102 245
2021/20221.652 17 76 37 68 322 258 59 80 104 64 92 475
2022/20232.078 265 305 176 153 200 311 19 149 325 13 134 28
2023/20241.849 183 183 235 168 226 310 91 57 45 50 81 220
2024/20251.087 85 237 187 388 190 0 0 0 0 0 0 0
Totale 14.841